EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Physiologically based absorption modeling to predict the bioequivalence of two apixaban formulations

Ting Luo iD, Lu Wang iD, Zourong Ruan, Honggang Lou iD, Dandan Yang iD, Zhiyang Wang, Pengfei Zhao iD, Bo Jiang iD

Clinical and Translational Science · 2024

DOI: 10.1111/cts.13819 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical and Translational Science, 2024. Verfasst von Ting Luo und 7 weiteren Autor:innen. Beteiligte Einrichtung: Center of Clinical Pharmacology, The Second Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, Zhejiang, China. Hauptthemen laut MEDLINE: Therapeutic Equivalency, Pyridones, Pyrazoles, Models, Biological. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The equivalence of absorption rates and extents between generic drugs and their reference formulations is crucial for ensuring therapeutic comparability. Bioequivalence (BE) studies are widely utilized and play a pivotal role in substantiating the approval and promotional efforts for generic drugs. Virtual BE simulation is a valuable tool for mitigating risks and guiding clinical BE studies, thereby minimizing redundant in vivo BE assessments. Herein, we successfully developed a physiologically based absorption model for virtual BE simulations, which precisely predicts the BE of the apixaban test and reference formulations. The modeling results confirm that the test and reference formulations were bioequivalent under both fasted and fed conditions, consistent with clinical studies. This highlights the efficacy of physiologically based absorption modeling as a powerful tool for formulation screening and can be adopted as a methodological and risk assessment strategy to detect potential clinical BE risks.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Therapeutic EquivalencyPyridonesPyrazolesModels, BiologicalHumansFactor Xa InhibitorsDrugs, GenericComputer SimulationAdministration, OralMale

Substanzen

PyridonesPyrazolesFactor Xa InhibitorsDrugs, Generic

Autor:innen und Institutionen

  • Center of Clinical Pharmacology, The Second Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, Zhejiang, China.

ORCID-Profile: Ting Luo, Lu Wang, Honggang Lou, Dandan Yang, Pengfei Zhao, Bo Jiang

Zitieren

APA

Luo, T., Wang, L., Ruan, Z., Lou, H., Yang, D., Wang, Z., Zhao, P., & Jiang, B. (2024). Physiologically based absorption modeling to predict the bioequivalence of two apixaban formulations. Clinical and Translational Science. https://doi.org/10.1111/cts.13819

Vancouver

Luo T, Wang L, Ruan Z, Lou H, Yang D, Wang Z, et al. Physiologically based absorption modeling to predict the bioequivalence of two apixaban formulations. Clinical and Translational Science. 2024. doi:10.1111/cts.13819

BibTeX
@article{Luo2024,
  author = {Luo, Ting and Wang, Lu and Ruan, Zourong and Lou, Honggang and Yang, Dandan and Wang, Zhiyang and Zhao, Pengfei and Jiang, Bo},
  title = {Physiologically based absorption modeling to predict the bioequivalence of two apixaban formulations},
  journal = {Clinical and Translational Science},
  year = {2024},
  doi = {10.1111/cts.13819}
}
Kostenlos starten →